Agilent Technologies, Inc. (ETR:AG8)
Germany · Delayed Price · Currency is EUR | Market Cap | 44.96B +25.2% |
| Revenue (ttm) | 6.41B +8.6% |
| Net Income | 1.25B +18.0% |
| EPS | 4.57 +18.4% |
| Shares Out | n/a |
| PE Ratio | 35.20 |
| Forward PE | 26.85 |
| Dividend | 0.89 (0.55%) |
| Ex-Dividend Date | Oct 6, 2026 |
| Volume | 30 |
| Open | 160.35 |
| Previous Close | 159.45 |
| Day's Range | 159.65 - 160.90 |
| 52-Week Range | 109.85 - 164.80 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 23, 2026 |
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti... [Read more]
Financial Performance
In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.
Financial numbers in USD Financial StatementsNews
Agilent expands portfolio with SureSelect Cancer Research Pan Heme
Agilent (A) Technologies announced the SureSelect Cancer Research Pan Heme. Developed in collaboration with experts at Roswell Park Comprehensive Cancer Center, the solution integrates DNA and RNA pro...
Agilent Expands Tumor Profiling Portfolio with SureSelect Cancer Research Pan Heme
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the SureSelect Cancer Research Pan Heme, a hybrid capture-based next-generation sequencing (NGS) research solu...
Agilent completes acquisition of Proscia for $240M in cash
Agilent (A) Technologies announced the successful completion of its previously announced acquisition of Proscia, a leading provider of digital-pathology software for clinical and life-sciences custome...
Agilent Completes Acquisition of Proscia
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Proscia®, a leading provider of digital-p...
Agilent launches 5987A single quadrupole mass selective detector with GC Assist
Agilent (A) Technologies announced the launch of the 5987A single quadrupole mass selective detector with GC Assist, along with MassHunter 14 software. When combined with the Agilent 8890B or 8860B…
Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the 5987A single quadrupole mass selective detector (MSD) with GC Assist, along with MassHunter ...
Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2026 after the stock market closes on Monday, Nov. 23. Th...
Agilent, University of Chicago announce collaboration to establish Agilent CoE
Agilent (A) Technologies and the University of Chicago announced a scientific collaboration to establish the Agilent Center of Excellence, CoE, for Energy Materials Research. The Agilent CoE will be b...
Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
SANTA CLARA, Calif. & CHICAGO--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of the world...
Agilent initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Justin Bowers initiated coverage of Agilent (A) with a Buy rating and $190 price target The firm believes Agilent’s has a strong position across multiple end markets…
Agilent initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Justin Bowers initiated coverage of Agilent (A) with a Buy rating and $190 price target
Agilent price target raised to $196 from $180 at TD Cowen
TD Cowen raised the firm’s price target on Agilent (A) to $196 from $180 and keeps a Buy rating on the shares. The firm adjusted targets in the life science…
Agilent to acquire Proscia in all-cash transaction valued at $240M
Agilent (A) Technologies announced it has entered into a definitive agreement to acquire Proscia, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash tran...
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology...
Agilent price target raised to $190 from $175 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Agilent (A) to $190 from $175 and keeps an Overweight rating on the shares as the firm refreshed models in its life…
Agilent price target raised to $190 from $180 at BofA
BofA raised the firm’s price target on Agilent (A) to $190 from $180 and keeps a Buy rating on the shares. The life science tools sector has further re-rated since…
Agilent Technologies Slides: Corporate presentation
Agilent Technologies has posted slides in relation to its latest quarterly earnings report, which was published on October 8, 2026.
Agilent price target raised to $195 from $175 at Barclays
Barclays raised the firm’s price target on Agilent (A) to $195 from $175 and keeps an Overweight rating on the shares. The firm adjusted targets in the life science and…
Agilent launches NovoStation Sample Preparation System
Agilent (A) Technologies announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample prepara...
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratorie...
Agilent launches Agilent BioTek Gen5 AI cell identification module
Agilent (A) Technologies announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmenta...
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that...
Agilent Technologies Transcript: U.S. All Stars Conference
Ignite transformation has driven growth, margin expansion, and innovation, focusing on autonomous labs and AI. China and Asia ex-China are key growth regions. LC/GC replacement cycles and service contracts support recurring revenue. Specialty CDMO targets mid-teens growth with new capacity in 2027. Disciplined capital allocation and targeted M&A support expansion.
Agilent launches TapeStationDx systems for NGS sample quality control
Agilent (A) Technologies announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company’s automated electrop...
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStation...